We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLSD market cap is 100.87M. The company's latest EPS is USD -0.4347 and P/E is -3.04.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 266k | 330k | 4k | 1.02M | 859k |
| Operating Income | -6.72M | -8.07M | -7.61M | -7.27M | -7.05M |
| Net Income | -7.83M | -9.66M | -9.28M | -9.11M | -9.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.17M | 7.89M | 29.58M | 1.33M | 8.23M |
| Operating Income | -30.3M | -17.94M | -627k | -30.28M | -24.84M |
| Net Income | -30.77M | -18.21M | 376k | -32.95M | -32.49M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 55.69M | 51.3M | 44.7M | 39.19M | 34.42M |
| Total Liabilities | 37.14M | 40.7M | 42M | 44.16M | 47.27M |
| Total Equity | 18.55M | 10.61M | 2.7M | -4.97M | -12.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.78M | 19.32M | 42.9M | 51.3M | 34.02M |
| Total Liabilities | 15.62M | 10.56M | 4.93M | 40.7M | 49.93M |
| Total Equity | 11.16M | 8.76M | 37.98M | 10.61M | -15.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.76M | -13.37M | -7.22M | -12.56M | -18.63M |
| Investing | -155k | -246k | -115k | -1.21M | -1.66M |
| Financing | 30.76M | 31.33M | 332k | 354k | 671k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.07M | -13.12M | -10.73M | -13.37M | -18.14M |
| Investing | 32.93M | -55k | N/A | -246k | -1.78M |
| Financing | 8.7M | 7.87M | 23.78M | 31.33M | 414k |
| Market Cap | 100.87M |
| Price to Earnings Ratio | -3.04 |
| Price to Sales Ratio | 11.99 |
| Price to Cash Ratio | 3.41 |
| Price to Book Ratio | -6.2 |
| Dividend Yield | - |
| Shares Outstanding | 74.72M |
| Average Volume (1 week) | 131.01k |
| Average Volume (1 Month) | 239.82k |
| 52 Week Change | 37.95% |
| 52 Week High | 2.12 |
| 52 Week Low | 0.650101 |
| Spread (Intraday) | 0.45 (26.16%) |
| Company Name | Clearside Biomedical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.clearsidebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
